ArticleTranslational andrology and urology2019

Favorable long-term toxicity for salvage low-dose rate prostate brachytherapy for recurrent prostate cancer after external beam radiotherapy from a phase II prospective trial (NRG Oncology/RTOG 0526).

Randall J Brenneman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.